Moreover, extrapyramidal symptoms have been described in the context of MAPT mutations affecting exon 10 splicing [8], and an abnormal striatal tau isoform content with an excess of 4R isoforms seems responsible for clinical parkinsonism in murine models of tauopathy resulting from altered exon 10 splicing [21]. The gene discussed is MAPT; the disease is Parkinson disease.